1. Home
  2. RPRX vs FLEX Comparison

RPRX vs FLEX Comparison

Compare RPRX & FLEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • FLEX
  • Stock Information
  • Founded
  • RPRX 1996
  • FLEX 1990
  • Country
  • RPRX United States
  • FLEX United States
  • Employees
  • RPRX N/A
  • FLEX N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • FLEX Electrical Products
  • Sector
  • RPRX Health Care
  • FLEX Technology
  • Exchange
  • RPRX Nasdaq
  • FLEX Nasdaq
  • Market Cap
  • RPRX 14.2B
  • FLEX 12.9B
  • IPO Year
  • RPRX 2020
  • FLEX 1994
  • Fundamental
  • Price
  • RPRX $31.03
  • FLEX $25.88
  • Analyst Decision
  • RPRX Strong Buy
  • FLEX Strong Buy
  • Analyst Count
  • RPRX 5
  • FLEX 6
  • Target Price
  • RPRX $41.60
  • FLEX $46.17
  • AVG Volume (30 Days)
  • RPRX 4.7M
  • FLEX 3.5M
  • Earning Date
  • RPRX 05-08-2025
  • FLEX 05-07-2025
  • Dividend Yield
  • RPRX 2.77%
  • FLEX N/A
  • EPS Growth
  • RPRX N/A
  • FLEX 46.11
  • EPS
  • RPRX 1.91
  • FLEX 2.48
  • Revenue
  • RPRX $2,263,576,000.00
  • FLEX $25,584,000,000.00
  • Revenue This Year
  • RPRX $34.04
  • FLEX N/A
  • Revenue Next Year
  • RPRX $6.10
  • FLEX $2.58
  • P/E Ratio
  • RPRX $16.63
  • FLEX $11.80
  • Revenue Growth
  • RPRX N/A
  • FLEX N/A
  • 52 Week Low
  • RPRX $24.05
  • FLEX $25.27
  • 52 Week High
  • RPRX $34.20
  • FLEX $45.10
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 36.17
  • FLEX 28.07
  • Support Level
  • RPRX $30.82
  • FLEX $32.07
  • Resistance Level
  • RPRX $31.85
  • FLEX $34.41
  • Average True Range (ATR)
  • RPRX 0.76
  • FLEX 1.35
  • MACD
  • RPRX -0.25
  • FLEX -0.27
  • Stochastic Oscillator
  • RPRX 9.57
  • FLEX 0.59

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About FLEX Flex Ltd.

Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.

Share on Social Networks: